文献速递艾滋病与性传播感染

抗逆转录病毒药物暂停后HIV控制(CHAMP)研究:从14项临床研究中识别的治疗后控制者

The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies.
PubMed 文献 · J Infect Dis · 2018-01-01

从14项研究中识别出67例治疗后控制者,定义为治疗中断后至少24周内三分之二及以上时间点病毒载量≤400拷贝/mL。早期治疗者中治疗后控制者比例高于慢性期治疗者(13% vs 4%,P < .001)。45%的治疗后控制者中断后病毒载量峰值≥1000拷贝/mL,33%峰值≥10000拷贝/mL;55%维持HIV控制2年,约20%维持控制≥5年。

要点

  • 早期HIV感染期启动ART者治疗后控制者比例高于慢性期启动者(13% vs 4%,P < .001)。
  • 45%的治疗后控制者中断后病毒载量峰值≥1000拷贝/mL,33%峰值≥10000拷贝/mL。
  • 55%的治疗后控制者维持HIV控制2年,约20%维持控制≥5年。

核心结论

  • 治疗后控制更常见于早期治疗的个体,常表现为早期短暂病毒反弹和HIV缓解持久性的异质性。
  • 这些结果可能提供机制见解,并对旨在实现HIV缓解的试验设计有启示。

研究设计与样本

  • 从14项研究中识别治疗后控制者,定义为治疗中断后至少24周内三分之二及以上时间点病毒载量≤400拷贝/mL。
  • 比较治疗后控制者与非控制者之间的病毒载量和CD4+细胞动态。

主要发现

  • 共识别67例治疗后控制者,其中38例在早期HIV感染期间启动ART。
  • 早期治疗者中治疗后控制者比例高于慢性期治疗者(13% vs 4%,P < .001)。
  • 在每周病毒载量监测的治疗后控制者中,45%中断后病毒载量峰值≥1000拷贝/mL,33%峰值≥10000拷贝/mL。
  • 55%的治疗后控制者维持HIV控制2年,约20%维持控制≥5年。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: HIV posttreatment controllers are rare individuals who start antiretroviral therapy (ART), but maintain HIV suppression after treatment interruption. The frequency of posttreatment control and posttreatment interruption viral dynamics have not been well characterized. METHODS: Posttreatment controllers were identified from 14 studies and defined as individuals who underwent treatment interruption with viral loads ≤400 copies/mL at two-thirds or more of time points for ≥24 weeks. Viral load and CD4+ cell dynamics were compared between posttreatment controllers and noncontrollers. RESULTS: Of the 67 posttreatment controllers identified, 38 initiated ART during early HIV infection. Posttreatment controllers were more frequently identified in those treated during early versus chronic infection (13% vs 4%, P < .001). In posttreatment controllers with weekly viral load monitoring, 45% had a peak posttreatment interruption viral load of ≥1000 copies/mL and 33% had a peak viral load ≥10000 copies/mL. Of posttreatment controllers, 55% maintained HIV control for 2 years, with approximately 20% maintaining control for ≥5 years. CONCLUSIONS: Posttreatment control was more commonly identified amongst early treated individuals, frequently characterized by early transient viral rebound and heterogeneous durability of HIV remission. These results may provide mechanistic insights and have implications for the design of trials aimed at achieving HIV remission.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Namazi G, Fajnzylber JM, Aga E, et al. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis. 2018. PMID: 30085241. doi:10.1093/infdis/jiy479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。